US drug regulator approves world's first RSV vaccine

US drug regulator approves world's first RSV vaccine The US Food and Drug Administration has approved a vaccine against respiratory syncytial virus (RSV) - an illness that kills thousands of Americans each year.

The vaccine still needs approval from the US Centers for Disease Control and Prevention before it can be rolled out to the public.

Officials say the vaccine, named Arexvy by the manufacturer GSK, is a major breakthrough that will save many lives. BBC News

See also:

• FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine US Food and Drug Administration
• FDA approves first-ever vaccine for RSV virus which kills 10,000 Americans every year The Daily Mail
• ‘A good day’: FDA approves world’s first RSV vaccine Nature